Skip to main content
Clinical Trials/JPRN-UMIN000030100
JPRN-UMIN000030100
Recruiting
未知

The study of gene mutation on the patients with idiopathic basal ganglia calcification (IBGC) in Japan - The study of gene mutation on the patients with idiopathic basal ganglia calcification (IBGC) in Japan

Gifu Pharmaceutical University0 sites500 target enrollmentDecember 1, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Idiopathic basal ganglia calcification (IBGC)
Sponsor
Gifu Pharmaceutical University
Enrollment
500
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2017
End Date
November 1, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • To exclude diseases which show calcification, because of some causes such as hypoparathyroism, pseudo hypoparathyroism, pseudopseudo hypoparathyroism (Albright's osteodystrophy), Down syndrome, collagen diseases, angiitis, infections, intoxication, trauma, radiation therapy and so on.

Outcomes

Primary Outcomes

Not specified

Similar Trials